These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10652630)

  • 1. Microbial conversion of methyl- and methoxy- substituted derivatives of 5H-indolo[2,3-b]quinoline as a method of developing novel cytotoxic agents.
    Osiadacz J; Kaczmarek L; Opolski A; Wietrzyk J; Marcinkowska E; Biernacka K; Radzikowski C; Jon M; Peczyńska-Czoch W
    Anticancer Res; 1999; 19(4B):3333-42. PubMed ID: 10652630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methoxy- and methyl-, methoxy-5,6,11-trimethyl-6H-indolo [2,3-b]quinolinium derivatives as novel cytotoxic agents and DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Opolski A; Wietrzyk J; Marcinkowska E; Boratyński J; Osiadacz J
    Anticancer Res; 1998; 18(4C):3133-8. PubMed ID: 9713522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
    Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
    Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
    Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
    J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 6-substituted 6H-indolo[2,3-b]quinolines as novel cytotoxic agents and topoisomerase II inhibitors.
    Kaczmarek L; Luniewski W; Zagrodzki B; Godlewska J; Osiadacz J; Wietrzyk J; Opolski A; Peczyńska-Czoch W
    Acta Pol Pharm; 2002; 59(3):199-207. PubMed ID: 12230247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticancer evaluation of certain indolo[2,3-b]quinoline derivatives.
    Chen YL; Hung HM; Lu CM; Li KC; Tzeng CC
    Bioorg Med Chem; 2004 Dec; 12(24):6539-46. PubMed ID: 15556770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
    Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.
    Lu CM; Chen YL; Chen HL; Chen CA; Lu PJ; Yang CN; Tzeng CC
    Bioorg Med Chem; 2010 Mar; 18(5):1948-57. PubMed ID: 20171108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
    Helissey P; Cros S; Giorgi-Renault S
    Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
    Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
    Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
    Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
    Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives.
    El Sayed I; Van der Veken P; Steert K; Dhooghe L; Hostyn S; Van Baelen G; Lemière G; Maes BU; Cos P; Maes L; Joossens J; Haemers A; Pieters L; Augustyns K
    J Med Chem; 2009 May; 52(9):2979-88. PubMed ID: 19364118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives.
    Beauchard A; Jaunet A; Murillo L; Baldeyrou B; Lansiaux A; Chérouvrier JR; Domon L; Picot L; Bailly C; Besson T; Thiéry V
    Eur J Med Chem; 2009 Oct; 44(10):3858-65. PubMed ID: 19427714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro biotransformation of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidation inhibitor and nitric oxide scavenger, in rat liver microsomes.
    Yenes S; Commandeur JN; Vermeulen NP; Messeguer A
    Chem Res Toxicol; 2004 Jul; 17(7):904-13. PubMed ID: 15257615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
    Badowska-Rosłonek K; Ciesielska A; Switalska M; Piskozub M; Peczyńska-Czoch W; Wietrzyk J; Kaczmarek Ł
    Acta Pol Pharm; 2016; 73(3):683-92. PubMed ID: 27476287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
    Wang N; Świtalska M; Wu MY; Imai K; Ngoc TA; Pang CQ; Wang L; Wietrzyk J; Inokuchi T
    Eur J Med Chem; 2014 May; 78():314-23. PubMed ID: 24686018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural comparisons of isomeric series of 7-aryl-benzo[h]pyrazolo[3,4-b]quinolines and 11-aryl-benzo[f]pyrazolo[3,4-b]quinolines.
    Portilla J; Quiroga J; Nogueras M; de la Torre JM; Cobo J; Low JN; Glidewell C
    Acta Crystallogr B; 2008 Feb; 64(Pt 1):72-83. PubMed ID: 18204214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic transformations of antitumor imidazoacridinone, C-1311, with microsomal fractions of rat and human liver.
    Wiśniewska A; Chrapkowska A; Kot-Wasik A; Konopa J; Mazerska Z
    Acta Biochim Pol; 2007; 54(4):831-8. PubMed ID: 18084652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.